TNFSF11 and gout: These observations are consistent with our findings on tophaceous gout (Figures 4C–4E) where we found that patients with tophi have higher circulating concentrations of the pro-osteoclastogenic RANKL and those with severe disease have even higher levels compared to mild or moderate disease, suggesting that RANKL plays a key role in bone erosion in gout.